角膜塑形镜用于儿童近视进展防控:美国眼科学会报告
本报告由美国眼科学会基于截至2018年8月21日的文献检索,评估角膜塑形镜(Ortho-K)对比框架眼镜或日戴接触镜标准屈光矫正对儿童青少年近视进展的减缓作用。纳入13项研究(1项Ⅰ级、11项Ⅱ级、1项Ⅲ级证据),多数在亚洲人群进行,Ortho-K在2年研究期内通常使眼轴增长减少约50%,对应眼轴变化约0.3 mm对0.6 mm、屈光度差异约0.5 D。年幼及瞳孔较大者可能效果更明显,但停戴或更换矫正方式后可能出现反弹,且接触镜相关微生物性角膜炎的安全风险仍需关注。
要点
- Ortho-K在2年研究期内通常使儿童眼轴增长减少约50%。
- 对应眼轴变化约0.3 mm对0.6 mm,屈光度差异约0.5 D。
- 年幼(6–8岁)及瞳孔较大者可能效果更明显,停戴后可能反弹。
核心结论
- 角膜塑形镜可能有效减缓儿童青少年近视进展,早期(6–8岁)开始可能效果更大,但安全性因微生物性角膜炎风险仍需关注。
研究设计与样本
- 美国眼科学会报告,检索PubMed、Cochrane图书馆及临床试验数据库至2018年8月21日,无日期限制但限英文,获得162条引文,最终纳入13篇文献进行全文评估。
- 纳入研究包括3项前瞻性随机临床试验、7项非随机前瞻性比较研究和3项回顾性病例系列;1项为Ⅰ级证据、11项为Ⅱ级证据、1项为Ⅲ级证据。
- 多数研究在亚洲族裔人群中进行;10/13项研究以眼轴长度变化为主要结局,3/13项以屈光度变化为主要结局。
主要发现
- 在这些研究中,Ortho-K在2年研究期内通常使眼轴增长减少约50%。
- 对应平均眼轴变化值约0.3 mm(Ortho-K组)对0.6 mm(对照组),对应屈光度典型差异约0.5 D。
- 年幼年龄组和瞳孔大于平均水平的个体可能从Ortho-K获得更大效果。
- 停戴或更换为其他屈光治疗后可能出现反弹。
关键数值与推荐
- 纳入研究证据等级:1项Ⅰ级、11项Ⅱ级、1项Ⅲ级。
- 主要结局:10/13项研究为眼轴长度变化,3/13项为屈光度变化。
- 2年研究期内Ortho-K通常减少眼轴增长约50%,眼轴变化约0.3 mm对0.6 mm,屈光度差异约0.5 D。
临床怎么用
- 对儿童青少年近视进展,可考虑Ortho-K作为减缓眼轴增长的选择,早期(6–8岁)开始可能获益更大。
- 验配和随访中需关注接触镜相关微生物性角膜炎风险,并告知停戴或更换矫正方式后可能反弹。
局限性
- 多数研究在亚洲族裔人群中进行,外推至其他人群需谨慎。
- 纳入研究证据等级不一,仅1项为Ⅰ级证据,多数为Ⅱ级证据。
- 安全性担忧源于接触镜佩戴可能导致微生物性角膜炎的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To review the published evidence to evaluate the ability of orthokeratology (Ortho-K) treatment to reduce myopic progression in children and adolescents compared with the use of spectacles or daytime contact lenses for standard refractive correction. METHODS: Literature searches of the PubMed database, the Cochrane Library, and the databases of clinical trials were last conducted on August 21, 2018, with no date restrictions but limited to articles published in English. These searches yielded 162 citations, of which 13 were deemed clinically relevant for full-text review and inclusion in this assessment. The panel methodologist then assigned a level of evidence rating to the selected studies. RESULTS: The 13 articles selected for inclusion include 3 prospective, randomized clinical trials; 7 nonrandomized, prospective comparative studies; and 3 retrospective case series. One study provided level I evidence, 11 studies provided level II evidence, and 1 study provided level III evidence. Most studies were performed in populations of Asian ethnicity. Change in axial length was the primary outcome for 10 of 13 studies and change in refraction was the primary outcome for 3 of 13 studies. In these studies, Ortho-K typically reduced axial elongation by approximately 50% over a 2-year study period. This corresponds to average axial length change values of approximately 0.3 mm for Ortho-K patients compared with 0.6 mm for control patients, which corresponds to a typical difference in refraction of approximately 0.5 diopters (D). Younger age groups and individuals with larger than average pupil size may have a greater effect with Ortho-K. Rebound can occur after discontinuation or change to alternative refractive treatment. CONCLUSIONS: Orthokeratology may be effective in slowing myopic progression for children and adolescents, with a potentially greater effect when initiated at an early age (6-8 years). Safety remains a concern because of the risk of potentially blinding microbial keratitis from contact lens wear.
引用
- VanderVeen DK, Kraker RT, Pineles SL, et al. Use of Orthokeratology for the Prevention of Myopic Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018. PMID: 30476518. doi:10.1016/j.ophtha.2018.11.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。